STRR:NASDAQStar Equity Holdings, Inc. Analysis
Data as of 2026-07-08 - not real-time
$11.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Star Equity Holdings is trading at roughly $11.1, comfortably above its 20‑day SMA and 50‑day SMA, indicating a short‑term bullish bias, while the 200‑day SMA remains lower, supporting a longer‑term uptrend. Technical signals are mixed: the RSI sits near 52 (neutral), the MACD histogram is negative and the MACD line sits below its signal, suggesting bearish momentum, and volume has been decreasing, which could limit upside. Fundamentally, the stock appears cheap – forward PE of about 9x versus an industry average of 31x, a price‑to‑book of 0.67 and price‑to‑sales of 0.22, and an upside potential of roughly 65% based on analyst targets. However, the company reports negative operating and net margins, a sizable operating loss, negative cash flow, and a debt‑to‑equity near 44%, raising concerns about sustainability. Recent material news highlights Q1 2026 results with new business wins and $2.6 million of merger synergies, which could improve near‑term earnings but do not yet offset the broader profitability challenges. The stock’s beta is low (≈0.3) indicating limited market‑wide volatility, yet its 30‑day price volatility is high (~38%) and liquidity is thin, with decreasing volume and a small market cap. Overall, the valuation suggests a potential bargain if the turnaround materializes, but significant financial and liquidity risks remain.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price near resistance at $11.8
- Neutral RSI indicating no clear overbought/oversold condition
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant upside potential (~65%) based on analyst targets
- Low valuation multiples relative to industry peers
- Recent Q1 wins and $2.6 M merger synergies improving earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Diversified multi‑segment business model offering resilience
- Low beta and defensive positioning within Industrials
- Potential for balance‑sheet improvement through asset sales or restructuring
Key Metrics & Analysis
Financial Health
Revenue Growth57.10%
Profit Margin-4.18%
P/E Ratio9.0
ROE-15.83%
ROA-2.13%
Debt/Equity43.85
P/B Ratio0.7
Op. Cash Flow$-7849000
Free Cash Flow$-13630750
Industry P/E31.0
Technical Analysis
TrendBullish
RSI52.2
Support$10.15
Resistance$11.80
MA 20$11.08
MA 50$10.67
MA 200$10.47
MACDBearish
VolumeDecreasing
Fear & Greed Index91.25
Valuation
Target Price$18.33
Upside/Downside65.17%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.30
Volatility38.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.